TLDR
- VSee Health shares surged 125% in premarket trading Tuesday after receiving FedRAMP High authorization from the Department of Health and Human Services for secure federal telehealth use.
- The certification allows any federal agency requiring high-level security to deploy VSee’s platform without additional vetting, opening access to Department of Defense, VA, and CDC contracts.
- VSee previously demonstrated platform reliability by deploying emergency telemedicine services after a cyberattack on a U.S. Virgin Islands hospital, processing 250+ backlogged studies.
- The authorization follows VSee’s October announcement of a $10+ million teleradiology contract and $5 million debt elimination from its SPAC merger.
- Analyst views remain divided, with one “Strong Buy” rating at $5.00 per share versus an AI model’s “Underperform” rating citing financial instability risks.
VSee Health stock rocketed higher Tuesday morning. The company received FedRAMP High authorization from the U.S. Department of Health and Human Services.
Shares jumped 125% in premarket trading on the news. The certification represents the highest level of federal security compliance for cloud-based services.
FedRAMP High authorization means federal agencies can use VSee’s telehealth platform for sensitive healthcare applications. No additional security vetting is required from individual departments.
“With FedRAMP High ATO, agencies can deploy VSee for secure, real-world patient care – anytime, anywhere,” CEO Dr. Milton Chen said. He described it as a major step for government partnerships.
The platform offers enterprise-grade encryption and HIPAA compliance. It includes healthcare information exchange interoperability and rapid multi-site activation capabilities.
VSee has earned HHS @FedRAMP High Authorization to Operate! This milestone further confirms our commitment to strong security for our telehealth solutions and more trust for our partners and clients!
Read: https://t.co/su4g3hDLs2#Telehealth #FedRAMP #AI #DigitalHealth pic.twitter.com/HGDoy9f9e1
— VSee (@VSee) October 28, 2025
Federal agencies including the Department of Defense, Veterans Affairs, and CDC can now adopt the technology. The authorization removes procurement barriers that previously blocked government contracts.
Crisis Response Proves Platform Capabilities
VSee demonstrated its system during a July emergency situation. A cyberattack disabled IT systems at Governor Juan F. Luis Hospital in St. Croix, U.S. Virgin Islands.
The company deployed a secure telemedicine system for HHS Assistant Secretary for Preparedness and Response. The solution maintained hospital operations throughout the crisis.
VSee’s platform processed over 250 backlogged radiology studies within days. Emergency services continued without interruption during the incident.
This real-world deployment likely influenced the FedRAMP High decision. It showed VSee could handle critical healthcare situations under pressure.
The company is developing AIMEE, focused on rural hospital transformation. The initiative uses AI-enabled digital health infrastructure for improved healthcare sustainability.
October Brings Multiple Catalysts
VSee announced several developments in October. On October 21, the company revealed a multi-year teleradiology contract exceeding $10 million.
The hospital system deal will double annual recurring revenue. Performance targets could add another $5 million to the contract value.
VSee eliminated over $5 million in legacy debt two days later. The SPAC merger debt removal strengthens the balance sheet and supports NASDAQ compliance.
The company previously received a delisting notice for falling below financial requirements. VSee was granted an extension to address the compliance issues.
Q2 2025 results showed $3.4 million in revenue, up 98% year-over-year. Gross margins improved to approximately 47% for the quarter.
The company remains unprofitable despite revenue growth. Net losses continue as cash burn remains a concern for investors.
Trading Volume and Market Reaction
Trading activity exploded following the FedRAMP announcement. Over 156 million shares traded compared to typical daily volume under 2 million.
The stock’s 52-week range spans $0.46 to $3.54. This reflects volatility common among micro-cap penny stocks.
Analyst coverage remains limited for the company. One analyst issued a “Strong Buy” rating with a $5.00 price target.
An AI-driven model rates VSee “Underperform” with a $0.50 target. The model points to financial instability and potential delisting risk.
VSee’s market capitalization sits around $10-15 million after the surge. The telehealth sector is projected to grow 20-25% annually through 2035.
The company now holds credentials that differentiate it from competitors. FedRAMP High status validates security for mission-critical government applications.
VSee can pursue contracts previously unavailable to the platform. Federal healthcare workloads requiring top-tier security clearance are now accessible markets.
The post VSee Health (VSEE) Stock Soars as Telehealth Platform Gets Federal Security Approval appeared first on Blockonomi.
This articles is written by : Nermeen Nabil Khear Abdelmalak
All rights reserved to : USAGOLDMIES . www.usagoldmines.com
You can Enjoy surfing our website categories and read more content in many fields you may like .
Why USAGoldMines ?
USAGoldMines is a comprehensive website offering the latest in financial, crypto, and technical news. With specialized sections for each category, it provides readers with up-to-date market insights, investment trends, and technological advancements, making it a valuable resource for investors and enthusiasts in the fast-paced financial world.